NCT07359859 2026-02-17A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting40 enrolled